Category Archives: RESEARCH

Kopchicks’ $10.5 million gift to fund student fellowships at MD Anderson UTHealth Graduate School

Just as he has changed the lives of people suffering from a devastating genetic disease, molecular endocrinologist John J. Kopchick, Ph.D., and his wife, Charlene, of Athens, Ohio, are paving the way for future scientists to do the same with a transformative $10.5 million gift to The University of Texas MD Anderson Cancer Center UTHealthContinue Reading

Scientists work to develop heat-resistant ‘cow of the future’

More than half the cattle in the world live in hot and humid environments, including about 40 percent of beef cows in the United States. By using genomic tools, researchers aim to produce an animal with superior ability to adapt to hot living conditions and produce top-quality beef. …read more Source:: Scientists work to developContinue Reading

Plants sacrifice ‘daughters’ to survive chilly weather

Plants adopt different strategies to survive the changing temperatures of their natural environments. This is most evident in temperate regions where forest trees shed their leaves to conserve energy during the cold season. In a new study, a team of plant biologists found that some plants may selectively kill part of their roots to surviveContinue Reading

Protein mingling under blue light

One of the current challenges in biology is to understand rapidly-changing phenomena. Interestingly, only a small fraction of them is due to proteins acting in isolation, the majority of biological events are regulated by proteins acting together in clusters. Researchers have developed a new tool, called “CRY2clust”, to trigger protein cluster formation in response toContinue Reading

FDA approves Rituxan Hycela (rituximab and hyaluronidase human) for subcutaneous injection in certain blood cancers

FDA approves Rituxan Hycela (rituximab and hyaluronidase human) for subcutaneous injection in certain blood cancers

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) approved Rituxan Hycela™ (rituximab and hyaluronidase human) for subcutaneous (under the skin) injection, for the treatment of adults with the following blood cancers: previously untreated and relapsed or refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma (DLBCL), andContinue Reading

Community  | Groups  | Members  | Register  | Blog  | Contact  | Terms of Engagement